Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-04-20 00:00:00 ET · period of report 2022-04-18 · accession 0001209191-22-025016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-20 | 2022-04-18 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +2,800 | 45.7K | +7% | +$6,776 |
| D | 2022-04-20 | 2022-04-18 | PCVX | Wassil Jim | COO | S - Sale+OE | $23.98 | -2,800 | 42.9K | -6% | -$67.1K |
| D | 2022-04-20 | 2022-04-18 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -2,800 | 233.1K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | M | A | 2,800 | $2.42 | 45,744 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-18 | S | D | 2,800 | $23.98 | 42,944 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $23.69 to $24.49. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2022-04-18 | M | D | 2,800 | $0.00 | 233,126 | D | $2.42 · — to 2029-12-16 | 2,800 Common Stock | (F3) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter. |